생식 유전학 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 컴포넌트별, 기술별, 시술 유형별, 용도별, 지역별 부문, 경쟁(2020-2030년)
Reproductive Genetics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented by Component, By Technology, By Procedure Type, By Application, By Region and Competition, 2020-2030F
상품코드:1796833
리서치사:TechSci Research
발행일:2025년 08월
페이지 정보:영문 180 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
생식 유전학 세계 시장 규모는 2024년에 58억 7,000만 달러로 평가되었습니다. 예측 기간 중 연평균 복합 성장률(CAGR)은 13.52%를 나타낼 전망이며, 2030년에는 125억 6,000만 달러에 이를 것으로 예측됩니다.
생식 유전학 세계 시장은 신흥 개발도상국의 유전공학에 대한 인식이 높아짐에 따라 크게 성장하고 있습니다. 또한, 의료 검사에 대한 의료비 상환 개선 및 새로운 진단센터를 개발하기 위한 정부 기관의 여러 투자와 함께 전 세계적으로 생식유전학에 대한 수요가 크게 증가하고 있습니다. 또한, 다양한 연령대의 여성들이 안전한 삶을 영위하기 위한 인식이 높아짐에 따라 고급 검사에 대한 인식이 높아지면서 생식유전학에 대한 수요가 더욱 증가하여 시장 성장을 가속화할 것으로 예측됩니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
58억 7,000만 달러
시장 규모 : 2030년
125억 6,000만 달러
CAGR : 2025년-2030년
13.52%
급성장 부문
차세대 시퀸싱
최대 시장
북미
시장 성장 촉진요인
유전성 질환 및 불임 발생률 증가
주요 시장 이슈
유전자 검사를 둘러싼 윤리적, 법적 문제
주요 시장 동향
비침습적 산전검사(NIPT)에 대한 수요 증가
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 소리
제5장 세계의 생식 유전학 시장 전망
시장 규모와 예측
금액별
시장 점유율과 예측
컴포넌트별(실험실 개발 검사, 키트 및 어세이, 시약 및 소모품)
기술별(차세대 시퀀싱, 중합효소 연쇄반응, In Situ Hybridization, 마이크로어레이)
시술 유형별(보인자 스크리닝, 산전 스크리닝, 착상전 유전자 검사, 불임 유전자 검사)
용도별(이수성, 단일 유전자 질환, 염색체 구조 이상, 기타)
지역별
기업별(2024년)
시장 맵
컴포넌트별
기술별
시술 유형별
용도별
지역별
제6장 북미의 생식 유전학 시장 전망
시장 규모와 예측
시장 점유율과 예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 생식 유전학 시장 전망
시장 규모와 예측
시장 점유율과 예측
유럽 : 국가별 분석
프랑스
독일
영국
이탈리아
스페인
제8장 아시아태평양의 생식 유전학 시장 전망
시장 규모와 예측
시장 점유율과 예측
아시아태평양 : 국가별 분석
중국
인도
일본
한국
호주
제9장 남미의 생식 유전학 시장 전망
시장 규모와 예측
시장 점유율과 예측
남미 : 국가별 분석
브라질
아르헨티나
콜롬비아
제10장 중동 및 아프리카의 생식 유전학 시장 전망
시장 규모와 예측
시장 점유율과 예측
중동 및 아프리카 : 국가별 분석
남아프리카공화국
사우디아라비아
아랍에미리트(UAE)
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향과 발전
최근 동향
인수합병(M&A)
제품 출시
제13장 Porter의 Five Forces 분석
업계내 경쟁
신규 참여 가능성
공급업체의 힘
고객의 힘
대체품의 위협/서비스
제14장 세계의 생식 유전학 시장 : SWOT 분석
제15장 경쟁 구도
CooperSurgical, Inc.
Centogene AG
Invitae Corporation
Illumina, Inc.
Myriad Genetics, Inc.
Thermo Fisher Scientific Inc.
Laboratory Corporation of America Holdings
Quest Diagnostics
Natera, Inc
Eurofins Scientific SE
제16장 전략적 제안
제17장 회사 소개 및 면책조항
LSH
영문 목차
영문목차
Global Reproductive Genetics Market was valued at USD 5.87 billion in 2024 and is expected to reach USD 12.56 billion by 2030 with a CAGR of 13.52% during the forecast period. The global market for Reproductive Genetics is experiencing significant growth, driven by the growing awareness towards genetic engineering in the developing countries, to get better. Additionally, growing reimbursement improvements for medical tests and initiative, running parallel to multiple investments by government organizations for developing new diagnostic centers, have significantly increased the demand for reproductive genetics across different parts of the globe. Additionally, significant growth in advanced testing along with increasing awareness among different age group women for leading safe life, are further expected to increase the demand for reproductive genetics, thereby fuelling the market growth.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 5.87 Billion
Market Size 2030
USD 12.56 Billion
CAGR 2025-2030
13.52%
Fastest Growing Segment
Next Generation Sequencing
Largest Market
North America
Key Market Drivers
Increasing Incidence of Genetic Disorders and Infertility
One of the primary growth drivers for the reproductive genetics market is the rising incidence of genetic disorders and infertility worldwide. According to the World Health Organization (WHO), approximately 10% to 15% of couples globally experience infertility, and the number is rising due to changing lifestyles, environmental factors, and delayed family planning. At the same time, the prevalence of heritable genetic conditions such as Down syndrome, cystic fibrosis, and thalassemia has heightened the demand for early detection and diagnosis through genetic testing.
Reproductive genetic testing methods, such as preimplantation genetic testing (PGT), carrier screening, and non-invasive prenatal testing (NIPT), help assess genetic risks in embryos and fetuses, allowing couples to make informed reproductive decisions. For instance, the Centers for Disease Control and Prevention (CDC) has reported that the number of assisted reproductive technology (ART) cycles performed in the United States has grown steadily, reaching nearly 330,000 cycles in 2021. Many of these ART cycles now integrate reproductive genetic tests to ensure healthy pregnancies.
Governments across Europe and Asia are also promoting national screening programs for conditions such as thalassemia and Tay-Sachs disease, particularly in high-prevalence regions. Such public health initiatives have further solidified the role of genetic diagnostics in reproductive health. Consequently, as the burden of infertility and inherited disorders continues to rise, reproductive genetic testing is becoming a critical part of reproductive healthcare globally.
Key Market Challenges
Ethical and Legal Concerns Surrounding Genetic Testing
One of the most pressing challenges facing the reproductive genetics market is the complex web of ethical and legal issues. Genetic testing, especially in the context of reproduction, raises serious concerns related to privacy, consent, genetic discrimination, and the potential for "designer babies." The ethical dilemma is particularly pronounced in prenatal and preimplantation genetic testing, where the ability to select embryos based on genetic characteristics has sparked debates about eugenics and social equity. Laws vary widely across countries. For example, Germany strictly regulates embryo selection, while the United States offers broader flexibility, often guided by private clinics' policies.
There is also concern about data protection. Genetic information is highly sensitive, and breaches can lead to discrimination in insurance and employment. While regulations like the Genetic Information Nondiscrimination Act (GINA) in the U.S. provide some protection, gaps still exist in areas such as long-term care insurance. Moreover, reproductive genetic testing may disproportionately benefit higher-income groups, exacerbating healthcare disparities. In countries without universal healthcare, the high cost of these tests may place them out of reach for many, even though government-supported initiatives are increasing access.
Key Market Trends
Rising Demand for Non-Invasive Prenatal Testing (NIPT)
A major trend reshaping the global reproductive genetics landscape is the increasing adoption of non-invasive prenatal testing (NIPT). This technique analyzes cell-free fetal DNA circulating in maternal blood to detect chromosomal abnormalities such as trisomy 21 (Down syndrome), trisomy 18, and trisomy 13 as early as the 10th week of pregnancy. NIPT has gained rapid clinical acceptance due to its safety (as it avoids amniocentesis or chorionic villus sampling), high sensitivity, and low false-positive rates. According to the American College of Obstetricians and Gynecologists (ACOG), NIPT is now recommended for all pregnant women regardless of age or risk level. This policy shift has dramatically expanded the target patient population.
Globally, many countries have integrated NIPT into public health strategies. For instance, in 2021, the Netherlands became one of the first countries to fully reimburse NIPT as part of routine prenatal screening. Similar policies are being adopted in Canada, Germany, and parts of Asia, including China and Japan. Furthermore, technological innovations such as single-molecule sequencing and machine learning-based analysis platforms are making NIPT more accurate and cost-effective. With a growing number of pregnancies being managed with NIPT, this trend is expected to substantially boost demand for reproductive genetic services over the next decade.
Key Market Players
CooperSurgical, Inc.
Centogene AG
Invitae Corporation
Illumina, Inc.
Myriad Genetics, Inc.
Thermo Fisher Scientific Inc.
Laboratory Corporation of America Holdings
Quest Diagnostics
Natera, Inc
Eurofins Scientific SE
Report Scope:
In this report, the Global Reproductive Genetics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Reproductive Genetics Market, By Component:
Laboratory Developed Tests
Kits & Assays
Reagents & Consumables
Reproductive Genetics Market, By Technology:
Next Generation Sequencing
Polymerase Chain Reaction
In Situ Hybridization
Microarrays
Reproductive Genetics Market, By Procedure Type:
Carrier Screening
Prenatal Screening
Preimplantation Genetic Testing
Infertility Genetic Testing
Reproductive Genetics Market, By Application:
Aneuploidy
Single Gene Disorder
Structural Chromosomal Abnormality
Others
Reproductive Genetics Market, By Region:
North America
United States
Mexico
Canada
Europe
France
Germany
United Kingdom
Italy
Spain
Asia-Pacific
China
India
South Korea
Japan
Australia
South America
Brazil
Argentina
Colombia
Middle East and Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Reproductive Genetics Market.
Available Customizations:
Global Reproductive Genetics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Reproductive Genetics Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Component (Laboratory Developed Tests, Kits & Assays, Reagents & Consumables)
5.2.2. By Technology (Next Generation Sequencing, Polymerase Chain Reaction, In Situ Hybridization, Microarrays)
5.2.3. By Procedure Type (Carrier Screening, Prenatal Screening, Preimplantation Genetic Testing, Infertility Genetic Testing)
5.2.4. By Application (Aneuploidy, Single Gene Disorder, Structural Chromosomal Abnormality, Others)
5.2.5. By Region
5.2.6. By Company (2024)
5.3. Market Map
5.3.1. By Component
5.3.2. By Technology
5.3.3. By Procedure Type
5.3.4. By Application
5.3.5. By Region
6. North America Reproductive Genetics Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Component
6.2.2. By Technology
6.2.3. By Procedure Type
6.2.4. By Application
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Reproductive Genetics Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Component
6.3.1.2.2. By Technology
6.3.1.2.3. By Procedure Type
6.3.1.2.4. By Application
6.3.2. Canada Reproductive Genetics Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Component
6.3.2.2.2. By Technology
6.3.2.2.3. By Procedure Type
6.3.2.2.4. By Application
6.3.3. Mexico Reproductive Genetics Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Component
6.3.3.2.2. By Technology
6.3.3.2.3. By Procedure Type
6.3.3.2.4. By Application
7. Europe Reproductive Genetics Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Component
7.2.2. By Technology
7.2.3. By Procedure Type
7.2.4. By Application
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. France Reproductive Genetics Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Component
7.3.1.2.2. By Technology
7.3.1.2.3. By Procedure Type
7.3.1.2.4. By Application
7.3.2. Germany Reproductive Genetics Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Component
7.3.2.2.2. By Technology
7.3.2.2.3. By Procedure Type
7.3.2.2.4. By Application
7.3.3. United Kingdom Reproductive Genetics Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Component
7.3.3.2.2. By Technology
7.3.3.2.3. By Procedure Type
7.3.3.2.4. By Application
7.3.4. Italy Reproductive Genetics Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Component
7.3.4.2.2. By Technology
7.3.4.2.3. By Procedure Type
7.3.4.2.4. By Application
7.3.5. Spain Reproductive Genetics Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Component
7.3.5.2.2. By Technology
7.3.5.2.3. By Procedure Type
7.3.5.2.4. By Application
8. Asia-Pacific Reproductive Genetics Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Component
8.2.2. By Technology
8.2.3. By Procedure Type
8.2.4. By Application
8.2.5. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Reproductive Genetics Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Component
8.3.1.2.2. By Technology
8.3.1.2.3. By Procedure Type
8.3.1.2.4. By Application
8.3.2. India Reproductive Genetics Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Component
8.3.2.2.2. By Technology
8.3.2.2.3. By Procedure Type
8.3.2.2.4. By Application
8.3.3. Japan Reproductive Genetics Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Component
8.3.3.2.2. By Technology
8.3.3.2.3. By Procedure Type
8.3.3.2.4. By Application
8.3.4. South Korea Reproductive Genetics Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Component
8.3.4.2.2. By Technology
8.3.4.2.3. By Procedure Type
8.3.4.2.4. By Application
8.3.5. Australia Reproductive Genetics Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Component
8.3.5.2.2. By Technology
8.3.5.2.3. By Procedure Type
8.3.5.2.4. By Application
9. South America Reproductive Genetics Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Component
9.2.2. By Technology
9.2.3. By Procedure Type
9.2.4. By Application
9.2.5. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Reproductive Genetics Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Component
9.3.1.2.2. By Technology
9.3.1.2.3. By Procedure Type
9.3.1.2.4. By Application
9.3.2. Argentina Reproductive Genetics Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Component
9.3.2.2.2. By Technology
9.3.2.2.3. By Procedure Type
9.3.2.2.4. By Application
9.3.3. Colombia Reproductive Genetics Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Component
9.3.3.2.2. By Technology
9.3.3.2.3. By Procedure Type
9.3.3.2.4. By Application
10. Middle East and Africa Reproductive Genetics Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Component
10.2.2. By Technology
10.2.3. By Procedure Type
10.2.4. By Application
10.2.5. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Reproductive Genetics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Component
10.3.1.2.2. By Technology
10.3.1.2.3. By Procedure Type
10.3.1.2.4. By Application
10.3.2. Saudi Arabia Reproductive Genetics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Component
10.3.2.2.2. By Technology
10.3.2.2.3. By Procedure Type
10.3.2.2.4. By Application
10.3.3. UAE Reproductive Genetics Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Component
10.3.3.2.2. By Technology
10.3.3.2.3. By Procedure Type
10.3.3.2.4. By Application
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Recent Developments
12.2. Mergers & Acquisitions
12.3. Product Launches
13. Porters Five Forces Analysis
13.1. Competition in the Industry
13.2. Potential of New Entrants
13.3. Power of Suppliers
13.4. Power of Customers
13.5. Threat of Substitute Products/Services
14. Global Reproductive Genetics Market: SWOT Analysis
